FilingReader Intelligence

Nhwa Pharmaceutical to cancel restricted stocks, reducing capital

June 13, 2025 at 05:24 PM UTCBy FilingReader AI

Jiangsu Nhwa Pharmaceutical (SZSE:002262) announced its plan to reduce its registered capital by cancelling 390,209 restricted stocks, repurchased at a price of CNY11.15 per share, totaling CNY4,350,830.35. The decision, approved at the company's recent shareholder meeting on June 13, will decrease the registered capital from CNY101,617,679.2 to CNY101,578,658.3.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Jiangsu Nhwa Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →